1. Updates on the Status of Vitamin D as a Risk Factor for Respiratory Distress Syndrome
   Vesara Ardhe Gatera et al, 2018, Advances in Pharmacological Sciences CrossRef
2. Vitamin D in the ICU: More Sun for Critically Ill Adult Patients?
   Pascal L. Langlois et al, 2018, Nutrition CrossRef
3. Calcitriol suppresses lipopolysaccharide‐induced alveolar bone damage in rats by regulating T helper cell subset polarization
   Chun‐Sheng Bi et al, 2019, J Periodont Res CrossRef
4. Metabolic engineering for the production of fat-soluble vitamins: advances and perspectives
   Panhong Yuan et al, 2019, Appl Microbiol Biotechnol CrossRef
5. Identification of amitriptyline HCl, flavin adenine dinucleotide, azacitidine and calcitriol as repurposing drugs for influenza A H5N1 virus-induced lung injury
   Fengming Huang et al, 2020, PLoS Pathog CrossRef
6. Vitamin D attenuates lung injury via stimulating epithelial repair, reducing epithelial cell apoptosis and inhibits TGF-β induced epithelial to mesenchymal transition
   ShengXing Zheng et al, 2020, Biochemical Pharmacology CrossRef
7. COVID-19 and vitamin D—Is there a link and an opportunity for intervention?
   Hrvoje Jakovac, 2020, American Journal of Physiology-Endocrinology and Metabolism CrossRef
8. A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin
   Anwarul Hasan et al, 2020, Journal of Biomolecular Structure and Dynamics CrossRef
9. Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection
   Soudeh Ghafouri-Fard et al, 2020, Vascular Pharmacology CrossRef
10. Perspective: improving vitamin D status in the management of COVID-19
    Maryam Ebadi et al, 2020, Eur J Clin Nutr CrossRef
11. Elective, Non-urgent Procedures and Aesthetic Surgery in the Wake of SARS–COVID-19: Considerations Regarding Safety, Feasibility and Impact on Clinical Management
    K. Kaye et al, 2020, Aesth Plast Surg CrossRef
12. Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment
    Virna Margarita Martín Giménez et al, 2020, Life Sciences CrossRef
13. Letter: does vitamin D have a potential role against COVID-19?
    Deepak Kumar et al, 2020, Aliment Pharmacol Ther CrossRef
14. Vitamin D can prevent COVID-19 infection-induced multiple organ damage
    Hatice Aygun, 2020, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
15. Letter: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity.
    Jose L Mansur, 2020, Aliment Pharmacol Ther CrossRef
16. Vitamin D deficiency and co-morbidities in COVID-19 patients – A fatal relationship?
    Hans K. Biesalski, 2020, NFS Journal CrossRef
17. Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166.
    Jose Manuel Quesada-Gomez et al, 2020, J Steroid Biochem Mol Biol CrossRef
18. Is Vitamin D One of the Key Elements in COVID-19 Days?
    M. T. Aslan et al, 2020, J Nutr Health Aging CrossRef
19. Vitamin D Supplementation: A Potential Approach for Coronavirus/COVID-19 Therapeutics?
    John F. Arboleda et al, 2020, Front. Immunol. CrossRef
20. A brief review of interplay between vitamin D and angiotensin‐converting enzyme 2: Implications for a potential treatment for COVID ‐19
    Aida Malek Mahdavi, 2020, Rev Med Virol CrossRef
21. The role of angiotensin-converting enzyme 2 in the pathogenesis of COVID-19: the villain or the hero?
    Josef Klhůfek, 2020, Acta Clinica Belgica CrossRef
22. The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions
    Tapan Behl et al, 2020, Life Sciences CrossRef
23. Diabetes Mellitus and Vitamin D Deficiency: Comparable Effect on Survival and a Deadly Association after a Myocardial Infarction
    Aneta Aleksova et al, 2020, JCM CrossRef
24. The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigms
    Craig Steven McLachlan, 2020, Clin Hypertens CrossRef
25. Can a combination of AT1R antagonist and vitamin D treat the lung complication of COVID-19?
    Mohamed Rafiullah, 2020, The American Journal of the Medical Sciences CrossRef
26. Reply to Jakovac: COVID-19, vitamin D, and type I interferon
    Maria Cristina Gauzzi et al, 2020, American Journal of Physiology-Endocrinology and Metabolism CrossRef
27. Supplementation with vitamin D in the COVID-19 pandemic?
    Fatemeh Hadizadeh, 2020 CrossRef
28. Vitamin D in COVID - 19: Dousing the fire or averting the storm? – A perspective from the Asia-Pacific
    Manju Chandran et al, 2020, Osteoporosis and Sarcopenia CrossRef
29. Associations between hypovitaminosis D and COVID-19: a narrative review
    Giancarlo Isaia et al, 2020, Aging Clin Exp Res CrossRef
30. El suplemento con altas dosis de vitamina D podría representar una alternativa promisoria para prevenir o tratar la infección por COVID-19
    José Luis Mansur et al, 2020, Clínica e Investigación en Arteriosclerosis CrossRef
31. The Impact of SARS-Cov-2 Virus Infection on the Endocrine System
    Noel Pratheepan Somasundaram et al, 2020 CrossRef
32. Vitamin D and COVID-19: Lessons from Spaceflight Analogs
    Sara R Zwart et al, 2020 CrossRef
33. Vitamin D for COVID-19: a case to answer?
    Adrian R Martineau et al, 2020, The Lancet Diabetes & Endocrinology CrossRef
34. Key Aspects in Nutritional Management of COVID-19 Patients
    Alfredo Fernández-Quintela et al, 2020, JCM CrossRef
35. Vitamin D deficiency in African Americans is associated with a high risk of severe disease and mortality by SARS-CoV-2
    Virna Margarita Martín Giménez et al, 2020, J Hum Hypertens CrossRef
36. Revisiting the role of vitamin D levels in the prevention of COVID-19 infection and mortality in European countries post infections peak
    Samer Singh et al, 2020, Aging Clin Exp Res CrossRef
37. Potential role of hypovitaminosis D and vitamin D supplementation during COVID-19 pandemic
    M Verdoia et al, 2020 CrossRef
38. Do nutrients and other bioactive molecules from foods have anything to say in the treatment against COVID-19?
    José L. Quiles et al, 2020, Environmental Research CrossRef
39. Could Vitamins Help in the Fight Against COVID-19?
    Thomas H Jovic et al, 2020, Nutrients CrossRef
40. LncRNA TUG1 reverses LPS-induced cell apoptosis and inflammation of macrophage via targeting MiR-221-3p/SPRED2 axis
    Lili Hu et al, 2020, Bioscience, Biotechnology, and Biochemistry CrossRef
41. Full title: The angiotensin-converting enzyme 2/angiotensin (1–7)/mas axis protects against pyroptosis in LPS-induced lung injury by inhibiting NLRP3 activation
    Haihua Huang et al, 2020, Archives of Biochemistry and Biophysics CrossRef
42. OBESITY, MALNUTRITION AND TRACE ELEMENTS DEFICIENCY IN THE COVID-19 PANDEMIC: AN OVERVIEW
    D. Fedele et al, 2020, Nutrition CrossRef
43. Impact of Vitamin D Deficiency on COVID-19—A Prospective Analysis from the CovILD Registry
    Alex Pizzini et al, 2020, Nutrients CrossRef
44. Should ACE2 be given a chance in COVID-19 therapeutics: A semi-systematic review of strategies enhancing ACE2
    Upinder Kaur et al, 2020, European Journal of Pharmacology CrossRef
45. Shining Light on the COVID-19 Pandemic: A Vitamin D Receptor Checkpoint in Defense of Unregulated Wound Healing
    Ronald M. Evans et al, 2020, Cell Metabolism CrossRef
46. Currently prescribed drugs in the UK that could upregulate or downregulate ACE2 in COVID-19 disease: a systematic review
    Hajira Dambha-Miller et al, 2020, BMJ Open CrossRef
47. Interaction between age and vitamin D deficiency in severe COVID-19 infection
    Fernando Macaya et al, 2020, Nutr Hosp CrossRef
48. Implications of Oxidative Stress and Potential Role of Mitochondrial Dysfunction in COVID-19: Therapeutic Effects of Vitamin D
    Natalia de las Heras et al, 2020, Antioxidants CrossRef
49. Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
    Zhila Maghbooli et al, 2020, PLoS ONE CrossRef
50. Repurposing existing drugs for COVID-19: an endocrinology perspective
    Flavio A. Cadegiani, 2020, BMC Endocr Disord CrossRef
51. VITAMIN D SUPPLEMENTATION AS A RATIONAL PHARMACOLOGICAL APPROACH IN THE COVID-19 PANDEMIC
    Leon Ferder et al, 2020, American Journal of Physiology-Lung Cellular and Molecular Physiology CrossRef
52. Vitamin D and Sex Differences in COVID-19
    Maria Teresa Pagano et al, 2020, Front. Endocrinol. CrossRef
53. The immuno-oncological challenge of COVID-19
    Lisa Derosa et al, 2020, Nat Cancer CrossRef
54. Angiotensin‐converting enzyme as a new immunologic target for the new SARS‐CoV‐2
    Shahin Hallaj et al, 2020, Immunol Cell Biol CrossRef
55. The benefits of Vitamin D in the COVID-19 pandemic: biochemical and immunological mechanisms
    Hadis Musavi et al, 2020, Archives of Physiology and Biochemistry CrossRef
56. Current State of Evidence: Influence of Nutritional and Nutrigenetic Factors on Immunity in the COVID-19 Pandemic Framework
    Sebastià Galmés et al, 2020, Nutrients CrossRef
57. Vitamin D deficiency in schizophrenia implications for COVID-19 infection
    D. Viani-Walsh et al, 2020, Ir. j. psychol. Med. CrossRef
58. Is vitamin D deficiency a risk factor for COVID‐19 in children?
    Kamil Yılmaz et al, 2020, Pediatric Pulmonology CrossRef
59. Magnesium und Schlaganfall
    , 2020, Zeitschrift für Orthomolekulare Medizin CrossRef
60. Evidence of protective role of Ultraviolet-B (UVB) radiation in reducing COVID-19 deaths
    Rahul Kalippurayil Moozhipurath et al, 2020, Sci Rep CrossRef
61. Could SARS-CoV-2-induced lung injury be attenuated by vitamin D?
    Dongqiong Xiao et al, 2020, International Journal of Infectious Diseases CrossRef
62. Is Vitamin D One of the Key Elements in COVID-19 Days?
    M. T. Aslan et al, 2020, J Nutr Health Aging CrossRef
63. Role of vitamin D in pathogenesis and severity of COVID-19 infection
    Maryam Honardoost et al, 2020, Archives of Physiology and Biochemistry CrossRef
64. Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity
    Joseph Mercola et al, 2020, Nutrients CrossRef
65. Is there a link between vitamin D status, SARS‐CoV ‐2 infection risk and COVID ‐19 severity?
    Davide Ferrari et al, 2020, Cell Biochem Funct CrossRef
66. Back to basics: review on vitamin D and respiratory viral infections including COVID-19
    Mamtha Balla et al, 2020, Journal of Community Hospital Internal Medicine Perspectives CrossRef
67. Potential approaches to combat COVID-19: a mini-review
    Zainab Sarwar et al, 2020, Mol Biol Rep CrossRef
68. Vitamin D high doses supplementation could represent a promising alternative to prevent or treat COVID-19 infection
    José Luis Mansur et al, 2020, Clínica e Investigación en Arteriosclerosis (English Edition) CrossRef
69. Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers
    Anshul Jain et al, 2020, Sci Rep CrossRef
70. Vitamin D and SARS-CoV-2 infection—evolution of evidence supporting clinical practice and policy development
    Daniel M. McCartney et al, 2020, Ir J Med Sci CrossRef
71. Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction – A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic
    Aida Santaolalla et al, 2020, Front. Physiol. CrossRef
72. A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor
    Murat Oz et al, 2020, Pharmacology & Therapeutics CrossRef
73. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections
    Petra Zimmermann et al, 2020, Arch Dis Child CrossRef
74. Renin–Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome
    Jaroslav Hrenak et al, 2020, IJMS CrossRef
75. COVID-19-Update für Senioren: Die Anti-SARS-CoV-2-Eigenschaften ausgewählter Mikronährstoffe
    Uwe Gröber, 2020, Zeitschrift für Orthomolekulare Medizin CrossRef
76. Micronutrients and Bioactive Substances: Their Potential Roles in Combating COVID-19
    Tibebeselassie Seyoum Keflie et al, 2020, Nutrition CrossRef
77. Zinc, Vitamin D and Vitamin C: Perspectives for COVID-19 With a Focus on Physical Tissue Barrier Integrity
    José João Name et al, 2020, Front. Nutr. CrossRef
78. Vitamin D Deficiency Is Inversely Associated with COVID-19 Incidence and Disease Severity in Chinese People
    Xia Luo et al, 2020 CrossRef
79. COVID-19 Disease and Vitamin D: A Mini-Review
    Mohamed Said Boulkrane et al, 2020, Front. Pharmacol. CrossRef
80. Potential benefits of dietary seaweeds as protection against COVID-19
    Kenichi Tamama, 2020 CrossRef
81. Investigating the Potential for Ultraviolet Light to Modulate Morbidity and Mortality From COVID-19: A Narrative Review and Update
    Shelley Gorman et al, 2020, Front. Cardiovasc. Med. CrossRef
82. The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities
    Xiao Cong Pang et al, 2020, Molecules CrossRef
83. VITAMIND AND ITS THERAPEUTIC RELEVANCE IN PULMONARY DISEASES
    Shaniya Ahmad et al, 2020, The Journal of Nutritional Biochemistry CrossRef
84. Dietary supplements, vitamins and minerals as potential interventions against viruses: Perspectives for COVID-19.
    Muhammad Torequl Islam et al, 2021, Int J Vitam Nutr Res CrossRef
85. Can Optimum Solar Radiation Exposure or Supplemented Vitamin D Intake Reduce the Severity of COVID-19 Symptoms?
    Joji Abraham et al, 2021, IJERPH CrossRef
86. The coronavirus disease (COVID-19) – A supportive approach with selected micronutrients
    Uwe Gröber et al, 2021, International Journal for Vitamin and Nutrition Research CrossRef
87. Does vitamin D supplementation prevent SARS-CoV-2 infection in military personnel? Review of the evidence
    Iain T Parsons et al, 2021, BMJ Mil Health CrossRef
88. Vitamin D and Immune Regulation: Antibacterial, Antiviral, Anti‐Inflammatory
    Emma L Bishop et al, 2021, JBMR Plus CrossRef
89. Association of Vitamin D Status with COVID-19 Infection and Mortality in the Asia Pacific region: A Cross-Sectional Study
    Dharmveer Yadav et al, 2021, Ind J Clin Biochem CrossRef
90. Implications of monsoon season and UVB radiation for COVID-19 in India
    Rahul Kalippurayil Moozhipurath et al, 2021, Sci Rep CrossRef
91. A notable key for estimating the severity of COVID-19: 25-hydroxyvitamin D status
    Merve Ergin Tuncay et al, 2021 CrossRef
92. Vitamin D deficiency is associated with COVID-19 positivity and severity of the disease.
    Mustafa Demir et al, 2021, J Med Virol CrossRef
93. Vitamin D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients
    Laurence Orchard et al, 2021 CrossRef
94. Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic-A comprehensive review.
    T Piticchio et al, 2021, J Endocrinol Invest CrossRef
95. Vitamin D3 to Treat COVID-19
    David E. Leaf et al, 2021, JAMA CrossRef
96. Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality
    Yifan Que et al, 2021, International Reviews of Immunology CrossRef
97. null
    Srđana Čulić, 2021 CrossRef
98. Exploring the link between vitamin D and clinical outcomes in COVID-19
    Prateek Lohia et al, 2021, American Journal of Physiology-Endocrinology and Metabolism CrossRef
99. Severe COVID-19 Infection Associated with Endothelial Dysfunction Induces Multiple Organ Dysfunction: A Review of Therapeutic Interventions
    Yujiro Matsuishi et al, 2021, Biomedicines CrossRef
100. Notable Developments for Vitamin D Amid the COVID-19 Pandemic, but Caution Warranted Overall: A Narrative Review
     Ronan Lordan, 2021, Nutrients CrossRef
101. Vitamin D and Its Potential Benefit for the COVID-19 Pandemic
     Nipith Charoenngam et al, 2021, Endocrine Practice CrossRef
102. Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits
     Anindita Banerjee et al, 2021, Expert Review of Anti-infective Therapy CrossRef
103. Emerging importance of ACE2 in external stratified epithelial tissues
     Nihal Kaplan et al, 2021, Molecular and Cellular Endocrinology CrossRef
104. Vitamin D and COVID-19: is there a role?
     Aysha Habib Khan et al, 2021, J Diabetes Metab Disord CrossRef
105. Retrospective analysis of vitamin D status on ınflammatory markers and course of the disease in patients with COVID-19 infection
     Y. A. Ünsal et al, 2021, J Endocrinol Invest CrossRef
106. Vitamin D Double-edged Sword Against COVID-19
     Fahima Danesh Pouya et al, 2021, Int J Infect CrossRef
107. Association of Calcitriol Supplementation with Reduced COVID-19 Mortality in Patients with Chronic Kidney Disease: A Population-Based Study
     Joaquim Oristrell et al, 2021, Biomedicines CrossRef
108. Prevalence of hypovitaminosis D in COVID-19 patients in the intensive care unit
     Mikhail V. Bychinin et al, 2021, Journal of Clinical Practice CrossRef
109. Synergy Between Vitamin D and Sex Hormones in Respiratory Functionality of Patients Affected by COVID-19
     Daniela Peruzzu et al, 2021, Front. Pharmacol. CrossRef
110. Insight from Nanomaterials and Nanotechnology towards covid-19
     Yengkhom Disco Singh et al, 2021, Sensors International CrossRef
111. Low Circulating Vitamin D in Intensive Care Unit–Admitted COVID-19 Patients as a Predictor of Negative Outcomes
     Mikhail V Bychinin et al, 2021 CrossRef
112. Nutritional management of individuals with obesity and COVID-19: ESPEN expert statements and practical guidance
     Rocco Barazzoni et al, 2021, Clinical Nutrition CrossRef
113. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D
     Ming-Yieh Peng et al, 2021, IJMS CrossRef
114. Vitamin D in the Covid-19 era: a review with recommendations from a G.I.O.S.E.G. expert panel
     Fabio Massimo Ulivieri et al, 2021, Endocrine CrossRef
115. Vitamin D and COVID‐19: Role of ACE2, age, gender, and ethnicity
     Bruk Getachew et al, 2021, J Med Virol CrossRef
116. The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy
     Shirin Kouhpayeh et al, 2021, IJMS CrossRef
117. Can Vitamin D Deficiency Increase the Susceptibility to COVID-19?
     Quratulain Maha et al, 2021, Front. Physiol. CrossRef
118. Vitamin D supplementation as an important factor in COVID-19 prevention and treatment: what evidence do we have?
     Juraj Smaha et al, 2020, Vnitř Lék CrossRef
119. Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study
     Juan F. Alcala-Diaz et al, 2021, Nutrients CrossRef
120. Vitamin D Levels in COVID-19 Outpatients from Western Mexico: Clinical Correlation and Effect of Its Supplementation.
     José Francisco Muñoz-Valle, 0 CrossRef
121. Essential sufficiency of zinc, ω-3 polyunsaturated fatty acids, vitamin D and magnesium for prevention and treatment of COVID-19, diabetes, cardiovascular diseases, lung diseases and cancer
     Michael J. Story, 2021, Biochimie CrossRef
122. Role of Vitamin D in COVID-19
     Rajeev Goyal et al, 2020 CrossRef
123. Lack of association between vitamin D insufficiency and clinical outcomes of patients with COVID-19 infection
     Alireza Davoudi et al, 2021, BMC Infect Dis CrossRef
124. Association of Vitamin D, Zinc and Selenium Related Genetic Variants With COVID-19 Disease Severity
     Nikola Kotur et al, 2021, Front. Nutr. CrossRef
125. Role of ACE 2 and Vitamin D: The Two Players in Global Fight against COVID-19 Pandemic
     Tapan Behl et al, 2021, Annals of the National Academy of Medical Sciences (India) CrossRef
126. Role of vitamins and minerals as immunity boosters in COVID-19
     Puneet Kumar et al, 2021, Inflammopharmacol CrossRef
127. null
     Kingsley Kwadwo Asare Pereko et al, 2021 CrossRef
128. Micronutrient therapy and effective immune response: a promising approach for management of COVID-19
     Fariba Lotfi et al, 2021, Infection CrossRef
129. Vitamin D Status and Clinical Outcomes in Acute Respiratory Distress Syndrome: A Secondary Analysis From the Assessment of Low Tidal Volume and Elevated End-Expiratory Volume to Obviate Lung Injury (ALVEOLI) Trial
     Sadeq A. Quraishi et al, 2021, J Intensive Care Med CrossRef
130. Lung-Centric Inflammation of COVID-19: Potential Modulation by Vitamin D
     Hana. M. A. Fakhoury et al, 2021, Nutrients CrossRef
131. Ultraviolet radiation, vitamin D, and COVID-19
     Matteo MEGNA et al, 2021, Ital J Dermatol Venereol CrossRef
132. Nutritional approach for increasing public health during pandemic of COVID-19: A comprehensive review of antiviral nutrients and nutraceuticals
     Vahideh Ebrahimzadeh-Attari et al, 2021, Health Promot Perspect CrossRef
133. Association of vitamin D deficiency with COVID‐19 infection severity: Systematic review and meta‐analysis
     Zhen Wang et al, 2021, Clinical Endocrinology CrossRef
134. Potential effect of astragaloside IV on the lipopolysaccharide induced inflammation via the inactivation of NF-κB signaling pathway
     Xuebo Yan et al, 2021, Phcog Mag CrossRef
135. Vitamin D supplementation and COVID-19 risk: a population-based, cohort study
     J. Oristrell et al, 2021, J Endocrinol Invest CrossRef
136. The Relationship Between Vitamin D and Infections Including COVID-19: Any Hopes?
     Rbab Taha et al, 2021, IJGM CrossRef
137. Mortality in Hemodialysis Patients with COVID-19, the Effect of Paricalcitol or Calcimimetics
     María Dolores Arenas Jimenez et al, 2021, Nutrients CrossRef
138. Vitamin D, infections and immunity
     Aiten Ismailova et al, 2021, Rev Endocr Metab Disord CrossRef
139. The sufficient vitamin D and albumin level have a protective effect on COVID-19 infection
     Somaieh matin et al, 2021, Arch Microbiol CrossRef
140. Vitamin D deficiency as a predictor of severity in patients with COVID-19 infection
     Mohammed Abd El Monem Teama et al, 2021, Science Progress CrossRef
141. Putative Role of Vitamin D for COVID-19 Vaccination
     Sheng-Kang Chiu et al, 2021, IJMS CrossRef
142. Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
     Enrique Ambrocio-Ortiz et al, 2021, Pharmaceuticals CrossRef
143. COVID-19 ed endocrinologia: il caso della tiroide, del diabete e dell’ipovitaminosi D
     Simone Antonini et al, 2021, L'Endocrinologo CrossRef
144. Factors regulating dynamics of Angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs
     Suvasmita Rath et al, 2021, Biomedicine & Pharmacotherapy CrossRef
145. Association between Vitamin D Status and Risk of Developing Severe COVID-19 Infection: A Meta-Analysis of Observational Studies
     Mohamed Ben-Eltriki et al, 2021, Journal of the American College of Nutrition CrossRef
146. Vitamin D in respiratory viral infections: a key immune modulator?
     Mostafa Vaghari-Tabari et al, 2021, Critical Reviews in Food Science and Nutrition CrossRef
147. Role of vitamins and minerals in immunity support in COVID-19
     S. V. Orlova et al, 2021, Medicinskij alfavit CrossRef
148. A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system
     Anastasia Williams et al, 2021, J. Neurovirol. CrossRef
149. Nanoantioxidant/Antioxidant Therapy in 2019-nCoV: A New Approach to Reactive Oxygen Species Mechanisms
     Ali Fathijouzdani et al, 2021, CDTH CrossRef
150. Association of Vitamin D receptor gene polymorphisms and clinical/severe outcomes of COVID-19 patients
     Rasoul Abdollahzadeh et al, 2021, Infection, Genetics and Evolution CrossRef
151. Vitamin D association with the renin angiotensin system in polycystic ovary syndrome
     Alexandra E. Butler et al, 2021, The Journal of Steroid Biochemistry and Molecular Biology CrossRef
152. Vitamin D and COVID-19: An Overview of Recent Evidence
     Drishti Ghelani et al, 2021, IJMS CrossRef
153. Covid-19 Susceptibility and Severity Might be Modified by Vitamin D Status: Theoretical and Practical Considerations
     Alex Tanner et al, 2021, CRMR CrossRef
154. The relationship between vitamin D, biomarkers and clinical outcome in hospitalised Covid-19 patients
     É. Breslin et al, 2021, Proc. Nutr. Soc. CrossRef
155. Role of ACE2-Ang (1–7)-Mas axis in post-COVID-19 complications and its dietary modulation
     Santoshi Sahu et al, 2021, Mol Cell Biochem CrossRef
156. Vitamin D and Cardiovascular Disease: Current Evidence and Future Perspectives
     Nicola Cosentino et al, 2021, Nutrients CrossRef
157. Factors Influencing Global Variations in COVID-19 Cases and Fatalities; A Review
     Osama Abu-Hammad et al, 2020, Healthcare CrossRef
158. The Effects of Vitamin D on Immune System and Inflammatory Diseases
     Tomoka Ao et al, 2021, Biomolecules CrossRef
159. Vitamin D may prevent COVID-19 induced pregnancy complication
     Ali Al-Kaleel et al, 2021, Medical Hypotheses CrossRef
160. The association between interferon lambda 3 and 4 gene single-nucleotide polymorphisms and the recovery of COVID-19 patients
     Pooneh Rahimi et al, 2021, Virol J CrossRef
161. Vitamin D Endocrine System and COVID‐19
     Roger Bouillon et al, 2021, JBMR Plus CrossRef
162. Association of lockdowns with the protective role of ultraviolet-B (UVB) radiation in reducing COVID-19 deaths
     Rahul Kalippurayil Moozhipurath et al, 2021, Sci Rep CrossRef
163. Single Treatment of Vitamin D3 Ameliorates LPS‐Induced Acute Lung Injury through Changing Lung Rodentibacter abundance
     Ai Jin et al, 2021, Molecular Nutrition Food Res CrossRef
164. Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes
     Iacopo Chiodini et al, 2021, Front. Public Health CrossRef
165. Vitamin D and COVID-19: where are we now?
     Victoria Contreras-Bolívar et al, 2021, Postgraduate Medicine CrossRef
166. Association of vitamin D status with COVID-19 and its severity
     Jae Hyun Bae et al, 2022, Rev Endocr Metab Disord CrossRef
167. Vitamin D regulation of immune function during covid-19
     Daniel D. Bikle, 2022, Rev Endocr Metab Disord CrossRef
168. The interacting physiology of COVID‐19 and the renin‐angiotensin‐aldosterone system: Key agents for treatment
     Eugenie R. Lumbers et al, 2022, Pharmacology Res & Perspec CrossRef
169. Antioxidant, anti-inflammatory and immunomodulatory roles of vitamins in COVID-19 therapy
     Aurelia Magdalena Pisoschi et al, 2022, European Journal of Medicinal Chemistry CrossRef
170. Patients with COVID-19 pneumonia with 25(OH)D levels lower than 12 ng/ml are at increased risk of death
     Juraj Smaha et al, 2022, International Journal of Infectious Diseases CrossRef
171. Perspectives on nano-nutraceuticals to manage pre and post COVID-19 infections
     Ankit Kumar Dubey et al, 2022, Biotechnology Reports CrossRef
172. The Role of Vitamin D in COVID-19 and the Impact of Pandemic Restrictions on Vitamin D Blood Content
     Agata Tomaszewska et al, 2022, Front. Pharmacol. CrossRef
173. Influence of exercise and vitamin D on the immune system against Covid-19: an integrative review of current literature
     Matheus Ribeiro Bizuti et al, 2022, Mol Cell Biochem CrossRef
174. Therapeutic Vitamin D Supplementation Following COVID-19 Diagnosis: Where Do We Stand?—A Systematic Review
     Angelina Bania et al, 2022, JPM CrossRef
175. The Role of Vitamin D in Supporting Health in the COVID-19 Era
     Alice Albergamo et al, 2022, IJMS CrossRef
176. null
     Cecilia Moy, 2022 CrossRef
177. Association of vitamin D status with COVID‐19 disease severity in pediatric patients: A retrospective observational study
     Solmaz Heidari et al, 2022, Health Science Reports CrossRef
178. Vitamin D Attenuates Airway Inflammation in Asthmatic Guinea Pigs Using Mammalian Target of Rapamycin-Mediated Autophagy
     Lin Zha et al, 2022, Journal of Interferon & Cytokine Research CrossRef
179. Network Pharmacology and Bioinformatics Analyses Identify Intersection Genes of Vitamin D3 and COVID-19 as Potential Therapeutic Targets
     Shanglin Wang et al, 2022, Front. Pharmacol. CrossRef
180. Vitamin D Regulation of Immune Function
     Daniel D Bikle, 2022, Curr Osteoporos Rep CrossRef
181. High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial
     Cédric Annweiler et al, 2022, PLoS Med CrossRef
182. Calcifediol for Use in Treatment of Respiratory Disease
     Marta Entrenas-Castillo et al, 2022, Nutrients CrossRef
183. A Narrative Review of Recent Studies on the Role of Vitamin D in the Prevention of Cardiac and Renal Risk and Additional Considerations for COVID-19 Vulnerability
     Aikaterini E. Panteli et al, 2022, CVP CrossRef
184. Effect of Cholecalciferol Supplementation on the Clinical Features and Inflammatory Markers in Hospitalized COVID-19 Patients: A Randomized, Open-Label, Single-Center Study
     Tatiana L. Karonova et al, 2022, Nutrients CrossRef
185. Vitamin D Endocrine System and COVID-19: Treatment with Calcifediol
     Jose Manuel Quesada-Gomez et al, 2022, Nutrients CrossRef
186. Medical Management and Nursing Care of a Patient with Acute Respiratory Distress Syndrome
     Rukiye Pınar BÖLÜKTAŞ et al, 2022, Bezmialem Science CrossRef
187. Vitamin D and interferon-γ co-operate to increase the ACE-2 receptor expression in primary cultures of human thyroid cells
     F. Coperchini et al, 2022, J Endocrinol Invest CrossRef
188. Vitamin D and COVID-19. Two years of research
     Andrey P. Fisenko et al, 2022, RPJ CrossRef
189. Vitamin D and the Ability to Produce 1,25(OH)2D Are Critical for Protection from Viral Infection of the Lungs
     Juhi Arora et al, 2022, Nutrients CrossRef
190. Vitamin D as the essential immunonutrient – the evidence base update: A review
     Svetlana G. Makarova et al, 2022, Pediatr. Con. Med. CrossRef
191. Intravenous calcitriol treatment benefits the homeostasis of CD4+ T cells and attenuates kidney injury in obese mice complicated with polymicrobial sepsis
     Chiu-Li Yeh et al, 2022, Nutrition CrossRef
192. Bibliometric analysis of the global research status and trends of the association between Vitamin D and infections from 2001 to 2021
     Wenfang He et al, 2022, Front. Public Health CrossRef
193. Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
     Laure-Alix Clerbaux et al, 2022, JCM CrossRef
194. Vitamin D: a potentially important secosteroid for coping with COVID-19
     THAYANNE S.S. ARAÚJO et al, 2022, An. Acad. Bras. Ciênc. CrossRef
195. The role of vitamin D deficiency on COVID-19: a systematic review and meta-analysis of observational studies
     Mehmet Onur Kaya et al, 2021, Epidemiol Health CrossRef
196. Vitamin D and its Possible Relationship to Neuroprotection in COVID-19: Evidence in the Literature
     Saray Quintero-Fabián et al, 2022, CTMC CrossRef
197. Antioxidants and clinical outcomes of patients with coronavirus disease 2019: A systematic review of observational and interventional studies
     Sahar Foshati et al, 2022, Food Science & Nutrition CrossRef
198. Visual analysis of the research trend and status on the association between vitamin D and immunity: From 2012 to 2021
     Xuemei Luo et al, 2022, Front. Nutr. CrossRef
199. Vitamin D—A prominent immunomodulator to prevent COVID ‐19 infection
     Sumel Ashique et al, 2022, Int J of Rheum Dis CrossRef
200. Effects of Vitamin D on the Renin–Angiotensin System and Acute Childhood Pneumonia
     Andrea Zovi et al, 2022, Antibiotics CrossRef
201. The role of vitamin D in the development and course of SARS-CoV-2 infection and other viral diseases
     Agnieszka Pytel et al, 2022, Ann. Acad. Med. Siles. CrossRef
202. 日本人のビタミンD不足・欠乏の実態
     Naoko TSUGAWA, 2021, KAGAKU TO SEIBUTSU CrossRef
203. Real world evidence of calcifediol or vitamin D prescription and mortality rate of COVID-19 in a retrospective cohort of hospitalized Andalusian patients
     Carlos Loucera et al, 2021, Sci Rep CrossRef
204. Interaction of Vitamin D with Peptide Hormones with Emphasis on Parathyroid Hormone, FGF23, and the Renin-Angiotensin-Aldosterone System
     Nejla Latic et al, 2022, Nutrients CrossRef
205. Correlation between Baseline 25(OH) Vitamin D Levels and Both Humoral Immunity and Breakthrough Infection Post-COVID-19 Vaccination
     Rami Abu Fanne et al, 2022, Vaccines CrossRef
206. Overcoming Infections Including COVID-19, by Maintaining Circulating 25(OH)D Concentrations Above 50 ng/mL
     Sunil Wimalawansa, 2022, PLMI CrossRef
207. Association between Vitamin D Status and Secondary Infections in Patients with Severe COVID-19 Admitted in the Intensive Care Unit of a Tertiary-Level Hospital in Turkey
     Lutfiye Karcioglu Batur et al, 2022, Diagnostics CrossRef
208. null
     Karsten Grote et al, 2023 CrossRef
209. Fraxinol attenuates LPS-induced acute lung injury by equilibrating ACE-Ang II-AT1R and ACE2-Ang (1-7)-Mas and inhibiting NLRP3
     Yan Wu et al, 2022, Pharmaceutical Biology CrossRef
210. Vitamin D3 and COVID-19 Outcomes: An Umbrella Review of Systematic Reviews and Meta-Analyses
     Fausto Petrelli et al, 2023, Antioxidants CrossRef
211. null
     Vânia Borba et al, 2023 CrossRef
212. Plasma 25(OH)D Level is Associated with the Nucleic Acid Negative Conversion Time of COVID-19 Patients: An Exploratory Study
     Changqiang Chen et al, 2023, IDR CrossRef
213. Potential Role of Vitamin D, ACE2 and the Proteases as TMPRSS2 and Furin on SARS-CoV-2 Pathogenesis and COVID-19 Severity
     Mesut Ortatatli et al, 2023, Archives of Medical Research CrossRef
214. Low vitamin D levels predict outcomes of COVID-19 in patients with both severe and non-severe disease at hospitalization
     Luigi di Filippo et al, 2023, Endocrine CrossRef
215. Mechanistic Insight into the role of Vitamin D and Zinc in Modulating Immunity Against COVID-19: A View from an Immunological Standpoint
     Nuzhat Ahsan et al, 2023, Biol Trace Elem Res CrossRef
216. Vitamin D Focused Approach to Nutritional Therapy for the Management of SARS-CoV-2 Pandemic: A Review
     Deepika Pawar et al, 2023, CNF CrossRef
217. Quantification of Vitamin D at Different Levels of Clinical Worsening of COVID-19
     Lai Yu Tsun et al, 2022, CDM CrossRef
218. Involvement of the secosteroid vitamin D in autoimmune rheumatic diseases and COVID-19
     Maurizio Cutolo et al, 2023, Nat Rev Rheumatol CrossRef
219. The role of vitamin D receptor and IL ‐6 in COVID‐19
     Ali Azmi et al, 2023, Molec Gen & Gen Med CrossRef
220. Impact of vitamin D deficiency in relation to the clinical outcomes of hospitalized COVID-19 patients
     Andhika Rachman et al, 2023, F1000Res CrossRef
221. All-cause and cause-specific mortality risks associated with calcium supplementation with or without vitamin D: A nationwide population-based study.
     Kyoung Jin Kim et al, 2023, J Intern Med CrossRef
222. Mechanistic approaching study in COVID-19 patients treated with high doses of vitamin D
     Mauro G. Silva et al, 2023 CrossRef
223. Physiological Basis for Using Vitamin D to Improve Health
     Sunil J. Wimalawansa, 2023, Biomedicines CrossRef
224. Comparison of Vitamin D and Resveratrol Performances in COVID-19
     Cristina Russo et al, 2023, Nutrients CrossRef
225. Impact of vitamin D deficiency in relation to the clinical outcomes of hospitalized COVID-19 patients
     Andhika Rachman et al, 2023, F1000Res CrossRef
226. Immunomodulatory Effects of Vitamin D in Respiratory Tract Infections and COVID-19 in Children
     Maria Nicolae et al, 2023, Nutrients CrossRef
227. Impact of vitamin D deficiency in relation to the clinical outcomes of hospitalized COVID-19 patients
     Andhika Rachman et al, 2023, F1000Res CrossRef
228. Research Progress on the Protective Effect of Vitamin D in Chronic Kidney Disease
     洪 周, 2023, ACM CrossRef
229. null
     Sebastian T. Lugg et al, 2024 CrossRef
230. null
     Yan Chun Li, 2024 CrossRef
231. Pharmacological evaluation of vitamin D in COVID-19 and long COVID-19: recent studies confirm clinical validation and highlight metformin to improve VDR sensitivity and efficacy
     Adel A. Gomaa et al, 2023, Inflammopharmacol CrossRef
232. Modeling risk factors of degree of severity of Coronavirus disease 2019 (COVID-19) infection in inpatient patients at Dr. M. Djamil Padang
     null Masrizal et al, 2023, Journal of Public Health Research CrossRef
233. Anti-inflammatory therapies for acute respiratory distress syndrome
     Denise Battaglini et al, 2023, Expert Opinion on Investigational Drugs CrossRef
234. Prevalence of vitamin D level disorders in therapeutic patients and features of their correction
     Lyudmila N. Eliseeva et al, 2023, Journal of Volgograd State Medical University CrossRef
235. Calcitriol attenuates poly(I:C)-induced lung injury in obese mice via modulating toll-like receptor 3- and renin-angiotensin system-associated signal pathways
     Chiu-Li Yeh et al, 2024, International Immunopharmacology CrossRef
236. Paradigm of immune dysregulation in coronavirus disease-2019 infection
     Om Saswat Sahoo et al, 2024, Explor Immunol CrossRef
237. Vitamin D Levels as a Marker of Severe SARS-CoV-2 Infection
     Lambros Athanassiou et al, 2024, Life CrossRef
238. The association between vitamin D deficiency and the clinical outcomes of hospitalized COVID-19 patients
     Andhika Rachman et al, 2024, F1000Res CrossRef
239. null
     William B. Grant, 2024 CrossRef
240. Immunomodulatory Effects of Vitamin D and Zinc on Viral Infection
     Muhammad Rizwan et al, 2024, Biol Trace Elem Res CrossRef